🇰🇷 Bw-A938U in South Korea

Bw-A938U (DOXACURIUM) regulatory status in South Korea.

Marketing authorisation

MFDS

  • Status: likely_approved

Bw-A938U in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Neuroscience approved in South Korea

Frequently asked questions

Is Bw-A938U approved in South Korea?

Yes. MFDS has authorised it.

Who is the marketing authorisation holder for Bw-A938U in South Korea?

Marketing authorisation holder not available in our data.